Prevalencia de altas concentraciones de lipoproteína (a) en embarazos complicados con restricción del crecimiento fetal intrauterino

Otero, Ana María; Bianchi, Ana; Dellepiane, Marisa; Pou Ferrari, Ricardo; Storch, Eduardo; Pons, Enrique; Alonso, Justo; Lens, Daniela; Attarian, Datevig; Mota, Nora; Ceria, Blanca; Ferrari, Alicia.
Rev. méd. Urug ; 21: 236-41, oct. 2005. tab, graf
Artículo en Español | BVSNACUY | ID: bnu-13017

Documentos relacionados

  1. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
  2. Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease.
  3. Non-genetic influences on lipoprotein(a) concentrations.
  4. Lipoprotein(a): from ancestral benefit to modern pathogen?
  5. A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment?
  6. Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory <i>&#945;</i>7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.
  7. Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits.
  8. Lipoproteína (a) como factor de riesgo independiente de enfermedad cardiovascular aterosclerótica
  9. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors.
  10. Prevalencia de altas concentraciones de lipoproteína (a) en embarazos complicados con restricción del crecimiento fetal intrauterino